Antibody therapy market propels at a robust CAGR of 13.2%


NEWARK, Del, July 15 2022 (GLOBE NEWSWIRE) — The global antibody therapy market is expected to reach US$727.78 billion by 2032, with a favorable rate of 13.2% during the forecast period. The availability of a strong pipeline of antibody therapies increases the company’s chances of increasing its revenue in the market.

As new drugs and pharmaceuticals for the treatment of diseases are approved, the market for antibody therapy is growing. Growing need for targeted pharmacological therapy and advancements in technology are driving the antibody therapy market.

FMI presents a comparative analysis of market growth rates and development prospects in the global Antibody Therapy market. According to Future Market Insights analysis, the demand in the global organic spices market is expected to increase with a robust CAGR of 13.2% during the forecast years 2022-2032.

Get a sample PDF of the report @

Key points to remember

  • The global antibody market will be driven by increasing prevalence of cancer and other chronic diseases, increasing regulatory approvals and drug launch, and increasing research partnerships to create a strong therapeutic pipeline.
  • COVID-19 has significantly influenced the global economy, affecting all nations by disrupting business in all sectors, regardless of size. The growing prevalence of COVID-19 patients has influenced the healthcare industry.
  • The antibody therapy industry has gained popularity due to an increase in demand for COVID-19 therapeutic development.
  • Strong market growth is predicted owing to government support for the launch of new treatments. One of the major drivers of the global monoclonal antibody market is the increasing incidence of cancer and other chronic diseases.
  • Rising regulatory approvals and new drug launches complement the market growth. The global risk of cancer is increasing rapidly and safer clinical treatment is being sought compared to traditional methods.
  • The North American antibody therapy market maintained a share of 49.1% in 2021. Due to the growing need for targeted drugs in the region.

Talk to our research [email protected]

Competitive landscape
Bristol-Myers Squibb, GlaxoSmithKline plc, Takeda Pharmaceuticals, Eli Lilly and Company, Merck & Co, Inc., Seagen, Johnson & Johnson, Novartis AG, Regeneron Pharmaceuticals and F. Hoffmann-La Roche Ltd. are some of the major companies featured in the full version of the report.

Major players exiting the market are implementing cost cutting measures. In the coming years, antibody therapy is expected to become more affordable and accessible. In addition, the extensive research projects will lead to the introduction of new monoclonal antibody therapy products. Antibodies have a robust therapeutic pipeline, resulting in a rapid growth rate.

More insights into Antibody Therapy Market

Due to increasing investments in innovative antibody treatments, the North American antibody therapy market maintained a share of 49.1% in 2021. Due to the growing need for targeted drugs in the region, the clinical studies have increased, contributing to the overall market growth.

The market should continue to be dominated by North America. The demand for antibody therapy is likely to be high, leading to rapid growth.
Many patients are drawn to therapy by low-cost treatments. Additionally, the high prevalence of cancer is fueling a massive demand for monoclonal antibody therapy. Antibody therapy is in high demand in this area. With the highest share, Asia-Pacific is the second largest region.

Growing aging populations increase rates of chronic disease. This ultimately creates a positive impact on the antibody therapy market. Moreover, Europe is a fast growing key player with a lot of potential. Europe has a high rate of investment, research and expansion.

Key Segments Covered in Antibody therapy Industry Research

By type:

  • Monoclonal antibodies
    • Oncology, Autoimmune disease
    • Infectious disease
    • Other
  • Antibody-drug conjugates

Per end user:

  • Hospitals
  • Specialized centers
  • Others

By region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

Download the PDF brochure @

About Antibody Therapy Market – Healthcare Market

In the latest study, FMI offers a detailed study of the global Antibody Therapy Market for the forecast period 2022 to 2032. This study also highlights the key drivers driving the Antibody Therapy market sales through a detailed segmentation. Our research studies serve as benchmark market guidelines for leading industry manufacturers, channel partners and government agencies to develop the way forward.

1. Summary

1.1. Global Market Outlook

1.2. Summary of statistics

1.3. Key Market Features and Attributes

1.4. MFI analysis and recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limits

3. Assessment of risks and market trends

3.1. Risk assessment

3.1.1. COVID-19 crisis and impact on demand for antibody therapy

3.1.2. Comparative analysis of the impact of COVID-19 with the previous crisis

3.1.3. Impact on market value (US$ millions)

3.1.4. Assessment by key countries

3.1.5. Assessment by key market segments

3.1.6. Action points and recommendation for suppliers

3.2. Key trends impacting the market

3.3. Formulation and product development trends

4. Market Context and Basic Data Points

ToC continued..!

Old Source:–with-a-favorable-cagr-of-13 -2-says-future-market-insights-301497824.html

About Health care Division at Future Market Insights

The Health care The Future Market Insights team offers expert analysis, quick research and strategic recommendations with the aim of providing authentic information and accurate results to help clients worldwide. With a repository of over 100 reports and over a million data points, the team has been insightfully analyzing the industry in over 50 countries for over a decade. The team provides a brief analysis of key trends, including the competitive landscape, profit margin, and research development efforts.

See related research reports:

Compression Therapy Market: The global compression therapy market is expected to register a market value of US$3.01 billion in 2022 and reach US$4.59 billion by 2030, expanding at a CAGR of 5.4%, indicating a steady positive growth of the market for the forecast period. (2022-2030).

Negative Pressure Wound Therapy Market: The global Negative Pressure Wound Therapy market size was valued at US$5.9 billion in 2021 and is expected to touch a valuation of US$6.2 billion in 2022 .

Cell Therapy Systems Market: The use of stem cells in medicine has been evident since 1968 with the performance of the first bone marrow transplant. The application of bone marrow transplantation is intended for the treatment of genetic blood disorders.

Osteoporosis Therapy and Fracture Healing Market: Osteoporosis indicates a chronic disease in which an individual loses bone mass density primarily in the hip or spine. Treatment for osteoporosis involves several oral and injectable medications.

Oxygen Therapy Equipment Market: The oxygen therapy equipment market is expected to reflect a CAGR of 7.4% during the period 2022-2032. The oxygen therapy equipment market is expected to reach US$6.4 billion in 2032, from US$3.1 billion in 2022.

Antibody Pair Kits Market – Antibody Pair Kits market is expected to register a CAGR of 7.7% during the forecast period and is expected to reach a market share of US$18.04 billion in 2032

Antibody Isotyping Kits Market – Antibody Isotyping Market is expected to grow at a CAGR of 11% during the forecast period 2022-2032

Antibody Purification Services Market – Antibody purification involves the isolation of antibodies from serum (polyclonal antibody), ascites fluid or culture supernatant of a hybridoma cell line (antibody monoclonal)

Phototherapy Treatment Market – Phototherapy Treatment Market is valued at US$530 million in 2021. The market is expected to grow at a CAGR of 5% until 2026, reaching US$675 million

About Future Market Insights (IMF)

Future Market Insights (ESOMAR certified market research organization and member of the Greater New York Chamber of Commerce) provides in-depth insights into the driving factors that increase demand in the market. It reveals opportunities that will drive market growth in various segments on the basis of source, application, sales channel, and end-use over the next 10 years.


Future Market Outlook Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
Such. : +1-845-579-5705
For sales inquiries: [email protected]
LinkedIn| Twitter| Blogs


Comments are closed.